0001209191-15-039175.txt : 20150506 0001209191-15-039175.hdr.sgml : 20150506 20150506083831 ACCESSION NUMBER: 0001209191-15-039175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150504 FILED AS OF DATE: 20150506 DATE AS OF CHANGE: 20150506 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 SECOND STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 150 SECOND STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sullivan Eric CENTRAL INDEX KEY: 0001601797 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 15835201 MAIL ADDRESS: STREET 1: GOODWIN PROCTER LLP STREET 2: 53 STATE ST CITY: BOSTON STATE: MA ZIP: 02109 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-04 0 0001293971 bluebird bio, Inc. BLUE 0001601797 Sullivan Eric C/O BLUEBIRD BIO, INC. 150 SECOND STREET CAMBRIDGE MA 02141 0 1 0 0 Principal Accounting Officer Common Stock 2015-05-04 4 M 0 250 20.70 A 566 D Common Stock 2015-05-04 4 M 0 166 24.47 A 732 D Common Stock 2015-05-04 4 S 0 189 131.2736 D 543 D Common Stock 2015-05-04 4 S 0 148 131.9554 D 395 D Common Stock 2015-05-04 4 S 0 79 132.9613 D 316 D Stock Options (right to buy) 20.70 2015-05-04 4 M 0 250 0.00 D 2023-12-02 Common Stock 250 7500 D Stock Option (right to buy) 24.47 2015-05-04 4 M 0 166 0.00 D 2024-03-03 Common Stock 166 5336 D The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 5, 2015. The range in prices for the transaction reported on this line was $130.50 to $131.50. The average weighted price was $131.2736. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The range in prices for the transaction reported on this line was $131.51 to $132.50. The average weighted price was $131.9554. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The range in prices for the transaction reported on this line was $132.75 to $133.27. The average weighted price was $132.9613. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. This option vests over a four-year period, at a rate of twenty-five percent(25%) on November 11, 2014 and in 36 equal monthly installments thereafter. This option vests over a four-year period, at a rate of twenty-five percent(25%) on January 1, 2015 and in 36 equal monthly installments thereafter. /s/ Jason F. Cole, Attorney-in-Fact 2015-05-06